At the beginning of September, Jonathan M. Pratt succeeded Thierry Bernard as CEO of Qiagen N.V. Bernard had led the biotech pioneer for nearly seven years.
https://european-biotechnology.com/wp-content/uploads/2026/09/EB.com_Qiagen_CEO_Jonathan_Pratt.jpg621553Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2026-09-07 11:06:012026-09-07 11:06:01New CEO took over the reins